Skip to main content
PLOS Medicine logoLink to PLOS Medicine
. 2005 Sep 27;2(9):e310. doi: 10.1371/journal.pmed.0020310

Tamoxifen and the Singing Voice

Andrew Herxheimer 1,
PMCID: PMC1236804  PMID: 16173841

My remark, in my recent Essay in PLoS Medicine [1], that deepening of the voice occurs with long-term use of tamoxifen for breast cancer needs qualification.

Several colleagues have rightly pointed out that the evidence for the effect is less clear than I implied: it comes from women who have experienced it [2], but there have been no controlled studies. A change in voice was looked for and not found among effects spontaneously reported in large trials of tamoxifen, but this was not specifically asked about and might well have been missed. It is also recognised that the voice sometimes becomes deeper during or after menopause, in the absence of tamoxifen.

To convey the uncertainty of the facts, I wish to amend my statement as follows: “The irreversible deepening of the voice that has been reported to occur with long-term use of tamoxifen for breast cancer is an example of a side effect that prescribers, manufacturers, and drug regulators seem to have considered trivial and have not investigated.”

Footnotes

Citation: Herxheimer A (2005) Tamoxifen and the singing voice. PLoS Med 2(9): e310.

References

  1. Herxheimer A. Communicating with patients about harms and risks. PLoS Med. 2005;2:e42. doi: 10.1371/journal.pmed.0020042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Goodare H. Tamoxifen and singing. Breast Care and Mastectomy (BCMA) Network. 1992;1992:2. (Spring) [Google Scholar]

Articles from PLoS Medicine are provided here courtesy of PLOS

RESOURCES